RT Journal Article
SR Electronic
T1 An international comparison of age and sex dependency of COVID-19 Deaths in 2020 - a descriptive analysis
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.03.11.21253420
DO 10.1101/2021.03.11.21253420
A1 Peter Bauer
A1 Jonas Brugger
A1 Franz König
A1 Martin Posch
YR 2021
UL http://medrxiv.org/content/early/2021/03/12/2021.03.11.21253420.abstract
AB COVID-19 mortality, the number of reported COVID-19 deaths per 100,000 persons observed so far, is described in 15 European countries and the USA depending on age groups and sex for the full year 2020. It is contrasted to the corresponding historic all-cause mortality per year depending on age and sex observed in these countries. Although there are substantial differences in the age and sex dependency of COVID-19 mortality between countries, there are some common features: Exponential increase with age is a good model to describe and analyse both COVID-19 and all-cause mortality above an age of 40 years, where almost all COVID-19 death occur. Age dependency is stronger for COVID-19 mortality than for all-cause mortality, males have an excess risk compared to women which flattens off with increasing age. Also with regard to calendar time, there were differences in the age and sex dependency between countries with the common tendency that male excess risk of COVID-19 mortality was smaller in the second half of the year.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:NA (The analysis is based on anonymized data, only)All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data (with the exception of the data for Austria) are publicly available. The data for Austria has been obtained from the GOEG Data Platform COVID-19 https://datenplattform-covid.goeg.at/ For details see the article.